GLP-1 Agonists – Bonus Vocabulary | 397
Skip Montreux and Samantha Vega provide bonus vocabulary explanations and examples for words and phrases used in D2B 396 - GLP-1 Agonists.
GLP-1 Agonists – Bonus Vocabulary | 397 Read More »
Skip Montreux and Samantha Vega provide bonus vocabulary explanations and examples for words and phrases used in D2B 396 - GLP-1 Agonists.
GLP-1 Agonists – Bonus Vocabulary | 397 Read More »
Skip Montreux and Dez Morgan get Down to Business with GLP-1 inhibitors — the drugs behind today’s weight-loss boom. They explain who the main players are, including Novo Nordisk and Eli Lilly, and compare their leading products. The discussion also looks at Pfizer’s acquisition of biopharma startup Metsera, and why this deal could significantly change the market.
GLP-1 Agonists | 396 Read More »
Skip Montreux and Dez Morgan provide bonus vocabulary explanations and examples for words and phrases used in D2B 364 - China's game-changing pharmaceutical and biotech industry.
China’s game-changing pharmaceutical and biotech industry – Bonus Vocabulary | 365 Read More »
Skip Montreux and Dez Morgan explore how China’s pharmaceutical and biotech sectors are reshaping the global healthcare landscape.
China’s game-changing pharmaceutical and biotech industry | 364 Read More »
Dez Morgan and Skip Montreux explore the fascinating history of Novo Nordisk and how they became Europe's most valuable company.
Novo Nordisk: Europe’s most valuable company | 289 Read More »